Roche announces positive interim results of risdiplam trials
Today Roche announced interim clinical data from the dose-finding parts of the FIREFISH and SUNFISH clinical trials investigating risdiplam as a treatment for spinal muscular atrophy.
Category: Updates
Roche announces positive interim results of risdiplam trials
Today Roche announced interim clinical data from the dose-finding parts of the FIREFISH and SUNFISH clinical trials investigating risdiplam as a treatment for spinal muscular atrophy.
TreatSMA met with the Roche UK team
On Monday 24 September, TreatSMA held a meeting with Roche UK to discuss our advocacy work and the company’s plans related to risdiplam.
TreatSMA met with the Roche UK team
On Monday 24 September, TreatSMA held a meeting with Roche UK to discuss our advocacy work and the company’s plans related to risdiplam.
An SMA gene therapy trial starting in London
The first European trial of AVXS-101, an experimental genetic therapy for spinal muscular atrophy, has opened in London.
An SMA gene therapy trial starting in London
The first European trial of AVXS-101, an experimental genetic therapy for spinal muscular atrophy, has opened in London.